FindTrial
Sign In

Role OF LAGHU VISHAGARBHA TAILA AND MARMA THERAPY IN THE MANAGEMENT OF SANDHIGATA VATA w.s.r. TO OSTEOARTHRITIS

A Comparative Clinical Study Of Local Application OF LAGHU VISHAGARBHA TAILA AND MARMA THERAPY IN THE MANAGEMENT OF SANDHIGATA VATA w.s.r. TO OSTEOARTHRITISâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019131
Enrollment
30
Registered
2019-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M199- Osteoarthritis, unspecified site

Interventions

Intervention1: Group A: 15 patients of this group will be treated with laghu vishagarbha taila â?¢Mode of administration â?? local gentle application on the affected joint. Control Intervention1

Sponsors

Uttrakhand Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA- 1.Patients fulfilling the diagnostic criteria of Sandhigata Vata (OA) 2.Patients aged between 30 -70 years will be included of either sex.

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA- 1.Patients having history of joint trauma, secondary and other systemic illness. 2.Patients suffering from any systemic diseases like tuberculosis, rheumatoid arthritis, gouty arthritis, psoriatic arthritis . 3.Patient suffering from infectious osteoarthritis.

Design outcomes

Primary

MeasureTime frame
Complete remission:100% relief Markedly improved:76-99% relief Moderately improved:51%-75% relief Improved:26%-50% relief Unchanged:0% â?? 25% relief Timepoint: Complete remission:100% relief Markedly improved:76-99% relief Moderately improved:51%-75% relief Improved:26%-50% relief Unchanged:0% â?? 25% relief—

Secondary

MeasureTime frame
Exacerbation in sign and symptomTimepoint: 90 days—

Countries

India

Contacts

Public ContactUrvashi

Rishikul campus

urvashipanwar2009@gmail.com9761055936

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026